| 注册
首页|期刊导航|国际肝胆胰疾病杂志(英文版)|Combination of tumor-associated regulatory T cell deletion and PD-1/PD-L1 blockade:A promising immunotherapy for hepatocellular carcinoma?

Combination of tumor-associated regulatory T cell deletion and PD-1/PD-L1 blockade:A promising immunotherapy for hepatocellular carcinoma?

Hua-Yu Yang Le-Jia Sun Yi-Lei Mao

国际肝胆胰疾病杂志(英文版)2018,Vol.17Issue(2):93-94,2.
国际肝胆胰疾病杂志(英文版)2018,Vol.17Issue(2):93-94,2.

Combination of tumor-associated regulatory T cell deletion and PD-1/PD-L1 blockade:A promising immunotherapy for hepatocellular carcinoma?

Combination of tumor-associated regulatory T cell deletion and PD-1/PD-L1 blockade:A promising immunotherapy for hepatocellular carcinoma?

Hua-Yu Yang 1Le-Jia Sun 1Yi-Lei Mao1

作者信息

  • 1. Department of Liver Surgery,Peking Union Medical College (PUMC) Hospital,PUMC & Chinese Academy of Medical Sciences,Beijing 100730,China
  • 折叠

摘要

引用本文复制引用

Hua-Yu Yang,Le-Jia Sun,Yi-Lei Mao..Combination of tumor-associated regulatory T cell deletion and PD-1/PD-L1 blockade:A promising immunotherapy for hepatocellular carcinoma?[J].国际肝胆胰疾病杂志(英文版),2018,17(2):93-94,2.

基金项目

This study was supported by grants from the CAMS Innova-tion Fund for Medical Sciences(2016-I2M-1-001),the National High-tech Research and Development Projects(863)(2015AA020303)and the National Natural Science Foundation of China(31500818). (2016-I2M-1-001)

国际肝胆胰疾病杂志(英文版)

OACSCDSCI

1499-3872

访问量0
|
下载量0
段落导航相关论文